The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Xilio Therapeutics, Inc(NASDAQ:XLO) 
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cy...
Share this website to your friends
Xilio Therapeutics Days Payable Outstanding ttm (DPO)
Xilio Therapeutics Op Cashflow Per Share ttm
Xilio Therapeutics Free Cashflow Per Share ttm
Xilio Therapeutics Cash Per Share ttm
Xilio Therapeutics (GAAP) P/E ratio ttm
Xilio Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.